---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-047120"
form_type: "8-K"
ticker: "SNES"
cik: "0001680378"
company_name: "SenesTech, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:01:04.807195+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SenesTech Q3 2024 revenue up 51% YTD; gross margin 65% record; operating expenses down 12%

## Summary
- YTD revenue $1.4M, +51% YoY; Q3 gross margin 65% vs 49% in prior year.
- Operating expenses down 12% in Q3; adjusted EBITDA loss narrowed 21% vs prior year.
- New products Evolve Rat and Evolve Mouse contributed 52% and 17% of Q3 revenue respectively.
- NYC rat contraception pilot bill approved; SenesTech only EPA-registered manufacturer; supply proposal under negotiation.
- International expansion: HK registration, Netherlands multi-pallet order, exclusive distributor selection in India, Pakistan, Chile, Brazil, Taiwan.

## SEC filing metadata
- accession: 0001628280-24-047120
- form_type: 8-K
- ticker: SNES
- cik: 0001680378
- company_name: SenesTech, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680378/000162828024047120/0001628280-24-047120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680378/000162828024047120/snes-20241112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-047120
- JSON: https://secwatch.observer/filing/0001628280-24-047120.json
- Plain text: https://secwatch.observer/filing/0001628280-24-047120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.